PREVALENCE AND RISK FACTORS OF HEPATITIS C INFECTION AMONG PREGNANT WOMEN IN ILORIN, KWARA STATE, NIGERIA

Main Article Content

Mutiat Odebisi-Omokanye
https://orcid.org/0000-0001-9825-3193
Augustine Udeze
Suleiman Mustapha
Abdulhameed Onoruoiza Ahmad-Tijani
Kayode Melody Oladimeji

Abstract

Hepatitis C virus (HCV) poses a significant risk to the well-being of pregnant women and their offspring with about 1.5 million new infections occurring annually. The data on the prevalence and associated risk factors among pregnant women in Nigeria remains limited. This study therefore aimed to determine the prevalence and associated risk factors of hepatitis C infection among pregnant women in Ilorin, Kwara State, Nigeria. This cross-sectional study enrolled 180 eligible pregnant women who visited and received antenatal care at Cottage and Civil Service Hospitals in Ilorin, Nigeria between November 2021 and January 2022. Demographic and clinical data were collected using a structured questionnaire while the antibody screening was via Enzyme-Linked Immunosorbent Assay (ELISA). The data were analyzed with IBM SPSS version 26 at p<0.05 significant level. Of the 180 pregnant women, 8 (4.4%) were positive for HCV. The highest proportion of HCV positivity was recorded among women aged 20-30 years (75%), those with tertiary education (100%), Civil Servants (100%), married women (100%), and those in the second trimester gestational age (100%). Furthermore, 87.5% of HCV-positive patients had a history of blood transfusion and 62.5% reported scarification. However, no significant statistical association was recorded between demographic characteristics, risk factors, and HCV seropositivity (p ˃ 0.05). Although the prevalence of active HCV infection among pregnant women in Ilorin was low, the outcome underscores the importance of routine screening of pregnant women for HCV to prevent maternal and neonatal complications in line with Sustainable Development Goal 3 on good health and wellbeing. This warrants further research for comprehensive data on HCV prevalence among pregnant women across Nigeria. 


 

Downloads

Download data is not yet available.

Article Details

How to Cite
Odebisi-Omokanye, M., Udeze , A., Mustapha, S., Ahmad-Tijani, A. O., & Oladimeji, K. M. (2024). PREVALENCE AND RISK FACTORS OF HEPATITIS C INFECTION AMONG PREGNANT WOMEN IN ILORIN, KWARA STATE, NIGERIA. ABUAD International Journal of Natural and Applied Sciences, 4(2), 81–87. https://doi.org/10.53982/aijnas.2024.0402.10-j
Section
Articles

References

Altinbas, S., Erdogan, M., and Danişman, N. (2010). The seroprevalences of HBs Ag and anti-HCV in pregnant women in Ankara. Arch Gynecol Obstet., 281, 371.

https://doi.org/10.1007/s00404-009-1145-6

Anayochukwu-Ugwu, N.N., Innocent, A., Enebe, J.B. (2023). Prevalence and Risk Factors of Hepatitis C Viral Infection Among Pregnant Women at a Tertiary Institution in Lagos, Nigeria. International Journal of Infectious Diseases and Therapy. Vol. 8, No. 1, 2023, pp. 23-30. https://doi.org/10.11648/j.ijidt.20230801.13

Arshad M., El-Kamary S.S. and Jhaveri, R. (2011). Hepatitis C virus infection during pregnancy and the newborn period - are there opportunities for treatment? Journal of Viral Hepatitis, 18(4), 229-236. https://doi.org/10.1111/j.1365-2893.2010.01413.x

Asafo-Agyei, K,O, and Samant, H. (2023). Pregnancy and Viral Hepatitis. Updated 2023 Mar 27. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK556026/

Bibi S, Dars S, Ashfaq S, Qazi RA and Akhund S. (2013). Seroprevalence and risk factors for hepatitis C virus (HCV) infection in pregnant women attending public sector tertiary care hospital in Hyderabad Sindh. Pakistan Journal of Medical Sciences, 29(2).

https://doi.org/10.12669/pjms.292.3211

Campion, A.L., Larouche, A., Fauteux‐Daniel, S. and Soudeyns, H. (2012). Pathogenesis of hepatitis C during pregnancy and childhood. Viruses, 4(12), 3531-3550.

https://doi.org/10.3390/v4123531

Elsheikh, R., Daak, A., Elsheikh, M., Karsany, M., and Adam, I. (2007). Hepatitis B virus and hepatitis C virus in pregnant Sudanese women. Virology Journal, 4, 104. doi: 10.1186/1743-422X-4-104. https://doi.org/10.1186/1743-422X-4-104

He S, Shuang G, Yinglan W, Wang L, Wang W, Wang A, Wang C, Wang X, Gao Q, Lu Z, Huang D, Wang Y, Mo PKH, Chen Z, Polin C and Wang Q. (2023). Prevalence and factors associated with hepatitis C among pregnant women in China: a cross-sectional study. Sci Rep 13, 759. https://doi.org/10.1038/s41598-023-27668-3

Kanaani, Z.A., Mahmud, S., Kouyoumjian, S.P. and Abu‐Raddad, L.J. (2018). The epidemiology of hepatitis C virus in Pakistan: systematic review and meta-analyses. Royal Society Open Science, 5(4), 180257.

https://doi.org/10.1098/rsos.180257

Mboto, C.I., Andy, I.E., Eni, O.I., and Jewell, A.P. (2010). Prevalence, sociodemographic characteristics and risk factors for hepatitis C infection among pregnant women in Calabar municipality, Nigeria. PubMed. https://pubmed.ncbi.nlm.nih.gov/22312384

Mukherjee, R., Burns, A., Rodden, D. and Chang, F. (2015). Diagnosis and Management of Hepatitis C Virus Infection. Journal of Laboratory Automation, 20(5), 519 -538.

https://doi.org/10.1177/2211068214563794

Nartey, Y.A., Okine, R., Seake-Kwawu, A. and Ghartey, G. (2023). Hepatitis C virus sero-prevalence, testing, and treatment capacity in public health facilities in Ghana, 2016-2021; A multi-centre cross-sectional study. PLoS ONE, 18(6):e0287580.

https://doi.org/10.1371/journal.pone.0287580

Ndong-Atome, G., Makuwa, M., Njouom, R., Branger, M., Brun-Vézinet, F., Mahé, A., Kazanji, M. (2008). Hepatitis C virus prevalence and genetic diversity among pregnant women in Gabon, central Africa. BMC Infectious Diseases, 8, 82. https://doi.org/10.1186/1471-2334-8-82

Njouom, R., Pasquier, C., Ayouba, A., Tejiokem, M., Vessiere, A. Mfoupouendoun, J., Tene, G., Izopet, J. (2005). Low risk of mother-to-child transmission of hepatitis C virus in

Yaounde, Cameroon: the ANRS 1262 study. American Journal of Tropical Medicine and Hygiene, 73, 460 - 466.

Obienu, O., Nwokediuko, S.C., Malu, A.O. and Lesi, O. (2011). Risk factors for hepatitis C virus transmission obscure in Nigerian patients. Gastroenterology Research and Practice, 1-4. https://doi.org/10.1155/2011/939673

Obinna, O.N., Amarachi, J.E., James, A.N., Solomon, C. and Emmanuel, S. (2012). A Survey for Antibodies to Hepatitis C virus among Women of Childbearing Age. Nature and Science, 10(9).

Ogunro, P. S., Adekanle, D. A., Fadero, F. F., Ogungbamigbe, T. O., and Oninla, S. O. (2007). Prevalence of anti-hepatitis C virus antibodies in pregnant women and their offspring in a tertiary hospital in Southwestern Nigeria. Journal of Infections in Developing Countries, 1 (3), 333-336. https://doi.org/10.3855/jidc.374

Omosigho, O., Osazee, E.I. and Akindele, O. (2022). Seroprevalence of hepatitis B and C viruses among pregnant women in Ilorin, Kwara State, Nigeria Microbes and Infectious Diseases3(3): 566-577

Onyekwere, C.A. and Hameed, L. (2014). Hepatitis B and C virus prevalence and association with demographics: report of population screening in Nigeria. Tropical Doctor, 0(0), 1-5.

https://doi.org/10.1177/0049475514560211

Oti, V.B., Mohammed, I.H., Ibrahim, Y. and Ibrahim, C. (2021). Epidemiologic Survey of HBV, HCV and HIV Infections in a Pregnant Women Population in Central Nigeria: A Cross-sectional Study. J Infect Dis Epidemiol, 7(2), 7:194. https://doi.org/10.23937/2474-3658/1510194

Owolabi, O.B., Adesina, K.T., Fadeyi, A. and Popoola, G. (2015). Hepatitis C virus (HCV) seroprevalence, antigenemia, and associated risk factors among pregnant women in Nigeria. PubMed, 53(4), 173-181. https://pubmed.ncbi.nlm.nih.gov/27182583

Pius, O.O., Ekundayo, I.O. and Abiodun, O.S. (2022). Sero-Prevalence of Transfusion Transmissible Hepatitis Viruses Among Blood Donors in Ilorin, Kwara State. International Journal of Applied Biology, 6(2). https://doi.org/10.20956/ijab.v6i2.18622

Ragusa, R., Corsaro, L.S., Frazzetto, E., Bertino, E., Bellia, M.A. and Bertino, G. (2020). Hepatitis C virus infection in children and pregnant women: an updated review of the literature on screening and treatments. AJP Rep. 10: e121-e127

https://doi.org/10.1055/s-0040-1709185

Reddick, K., Jhaveri, R., Gandhi, M., James, A.H. and Swamy, G.K. (2011). Pregnancy outcomes associated with viral hepatitis. Journal of Viral Hepatitis, 18(7).

https://doi.org/10.1111/j.1365-2893.2011.01436.x

Safir, A., Levy, A., Sikuler, E. and Sheiner, E. (2010). Maternal hepatitis B virus or hepatitis C virus carrier status is an independent risk factor for adverse perinatal outcomes. Liver International, 30(5), 765-770. https://doi.org/10.1111/j.1478-3231.2010.02218.x

Ugbebor, O., Aigbirior, M., Osazuwa, F. and Enabudoso, E. (2011). The prevalence of hepatitis B and C viral infections among pregnant women. North American Journal of Medicine and Science, 3(5), 3: 238-241. https://doi.org/10.4297/najms.2011.3238

Ugwu, I.A., Anayochukwu-Ugwu, N.N. and Ndibuagu, E.O. (2023). Knowledge of Hepatitis C Viral Infection, Prevalence and Access to Screening among Pregnant Women in Lagos Nigeria. Arch Obstet Gynecol Reprod Med (AOGRM), 6(1): 194-204.

WHO. Global Progress Report on HIV, Viral Hepatitis and Sexually Transmitted Infections. 2021. Available online: https://www.who.int/publications/i/item/9789240027077

Zahran KM, Badary MS, Agban MN and Abdel Aziz HR. 2010. Pattern of hepatitis virus infection among pregnant women and their newborns at the Women's Health Center of Assiut University, Upper Egypt. International Journal of Gynecology and Obstetrics, 111, 71-174. https://doi.org/10.1016/j.ijgo.2010.06.013

Zenebe Y, Mulu W, Yimer M and Abera B (2015). Sero-prevalence and risk factors of hepatitis C virus infection among pregnant women in Bahir Dar city, Northwest Ethiopia: a cross-sectional study. Pan African Medical Journal, 21: 158.

https://doi.org/10.11604/pamj.2015.21.158.6367